NCT05745038 A Single Arm Pilot Trial of a Social Network Intervention
| NCT ID | NCT05745038 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Rochester |
| Condition | Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 330 participants |
| Start Date | 2023-11-29 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 330 participants in total. It began in 2023-11-29 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to see if a social network support program (SOcial Networks to Activate Trust \& Adherence or SONATA) is helpful for older individuals receiving cancer treatment. The SONATA program will last for about 4 months. There are a total of 6 coaching sessions. The first 5 sessions will be held approximately every 1 to 2 weeks. Session 6 or the final session will be held approximately 1 to 2 months after session 5. Each session will last for about 1 to 2 hours.
Eligibility Criteria
Patient Inclusion Criteria: 1. Age ≥60 years 2. A diagnosis of advanced or likely incurable cancer, as determined by the primary oncologist 3. Able to speak English 4. Able to provide informed consent Exclusion Criteria: 1\) Any psychiatric or cognitive impairments interfering with participation as determined by the primary oncology team Network Members: Inclusion Criteria: 1. Age ≥18 years 2. Identified as a network member by patient subjects (up to 10 network members) 3. Able to speak English 4. Able to provide informed consent. Exclusion Criteria: None
Contact & Investigator
Kah Poh Loh
PRINCIPAL INVESTIGATOR
University of Rochester
Frequently Asked Questions
Who can join the NCT05745038 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05745038 currently recruiting?
Yes, NCT05745038 is actively recruiting participants. Contact the research team at Kahpoh_Loh@URMC.Rochester.edu for enrollment information.
Where is the NCT05745038 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT05745038 clinical trial?
NCT05745038 is sponsored by University of Rochester. The principal investigator is Kah Poh Loh at University of Rochester. The trial plans to enroll 330 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.